Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Q4 2018 Amneal Pharmaceuticals Inc Earnings Call Transcript

Feb 28, 2019 / 01:30PM GMT
Release Date Price: €10.72 (+0.75%)
Operator

Good morning, and welcome to the Amneal Pharmaceuticals Fourth Quarter and Full Year 2018 Earnings Conference Call. (Operator Instructions) Please note that this event is being recorded.

At this time, I would like to turn the conference over to Mark Donohue, Vice President of Investor Relations and Corporate Communications. Please go ahead, sir.

Mark J. Donohue
Amneal Pharmaceuticals, Inc. - VP of IR & Corporate Communications

Thank you. Good morning, everyone. Welcome to Amneal's Fourth Quarter and Full Year 2018 Earnings Call. Earlier this morning, we issued a press release reporting our earnings for the fourth quarter and full year. The press release as well as the slides that will be presented on this call are available on our website at www.amneal.com. We are conducting a live webcast of this call, a replay of which will also be available on our website after its conclusion.

Please note that today's call is copyrighted material of Amneal. It cannot be rebroadcasted

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot